We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$356M
AUM Growth
-$3.37M
Cap. Flow
-$42.2M
Cap. Flow %
-11.85%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$30.1M
2
ALKS icon
Alkermes
ALKS
+$12M

Sector Composition

Rank Sector Weight
1 Healthcare 92.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$255M 71.55%
11,275,871
-1,334,669
-11% -$30.1M
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$75.2M 21.12%
2,679,835
INDA icon
3
iShares MSCI India ETF
INDA
$6.71B
$13.5M 3.79%
320,000
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$12.6M 3.54%
400,000
ALKS icon
5
Alkermes
ALKS
$8.82B
-603,790
Closed -$12M

Similar funds

Meditor Group's Q1 2021 Portfolio in Review

As of Q1 2021, Meditor Group held 5 positions worth $356M, down 0.94% from $359M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Meditor Group withdrew a net $42.2M in Q1 2021, closing 1 position and reducing 1 holding. Its most notable exit was Alkermes, an estimated $12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 93% a quarter earlier.

  • Meditor Group's biggest Q1 2021 reduction was Exelixis, cutting an estimated $30.1M.
  • Meditor Group fully exited Alkermes in Q1 2021, selling an estimated $12M.
  • Meditor Group's ten largest holdings make up 100% of its $356M portfolio in Q1 2021.
  • Meditor Group opened 0 new positions and closed 1 in Q1 2021.
  • Meditor Group's portfolio value fell 0.94% quarter-over-quarter to $356M.

Based on Meditor Group's 13F filing for Q1 2021, filed 9 Apr 2021.